title: Hyperhomocysteinemia in high-aged subjects: relation of B-vitamins, folic acid, renal function and the methylenetetrahydrofolate reductase mutation.
abstract: Moderate hyperhomocysteinemia is an atherogenic risk factor and plays an important role in geriatrics. Here, we have investigated the role of hyperhomocysteinemia in two elderly groups: 104 longeval subjects of 85-102 years, 100 seniors aged 65-75 years, and 75 controls of 19-60 years. Elevated homocysteine levels were found in 58% of longeval subjects in comparison with 32% in seniors. The homocysteine level in serum correlated positively with age as well as serum creatinine, and inversely with serum folate, but there was no correlation with serum B-vitamins. The frequency of vitamin B deficiency in serum of longeval subjects compared to seniors was as follows: vitamin B6 43% vs. 22%, vitamin B12 20% vs. 8%, and folic acid 1% in both groups. Increased serum creatinine levels (> 1.1 mg/dl) were found in 63% of the longeval subjects and in 32% of seniors. The 677-missense mutation in the methylenetetrahydrofolate reductase (MTHFR) gene, responsible for moderate homocysteine elevation, was found in 35, 37 and 27% of alleles in longeval persons, senior subjects and younger controls, respectively, showing no significant difference in frequency distributions of the MTHFR gene mutation. It can be concluded that hyperhomocysteinemia is very common with increased age. Its importance as an atherogenic risk factor with advanced age has to be clarified.
authors.affiliation: Zentrallabor der Universitätskliniken des Saarlandes, Homburg, Germany. kchwher@med-rz.uni-sb.de
authors.forename: W
authors.initials: W
authors.lastname: Herrmann
authors.forename: S
authors.initials: S
authors.lastname: Quast
authors.forename: M
authors.initials: M
authors.lastname: Ullrich
authors.forename: H
authors.initials: H
authors.lastname: Schultze
authors.forename: M
authors.initials: M
authors.lastname: Bodis
authors.forename: J
authors.initials: J
authors.lastname: Geisel
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000375:Aging / Q000502:physiology; D001161:Arteriosclerosis / Q000453:epidemiology / Q000209:etiology* / Q000378:metabolism; D005260:Female; D005492:Folic Acid / Q000097:blood* / Q000378:metabolism; D006710:Homocysteine / Q000097:blood; D006801:Humans; D020138:Hyperhomocysteinemia / Q000150:complications* / Q000503:physiopathology*; D007677:Kidney Function Tests; D008297:Male; D042965:Methylenetetrahydrofolate Reductase (NADPH2); D008875:Middle Aged; D015999:Multivariate Analysis; D009154:Mutation; D000587:Oxidoreductases Acting on CH-NH Group Donors / Q000235:genetics*; D012044:Regression Analysis; D018570:Risk Assessment; D012307:Risk Factors; D018709:Statistics, Nonparametric; D014805:Vitamin B 12 / Q000097:blood* / Q000378:metabolism
chemical_list: D006710:Homocysteine; D005492:Folic Acid; D000587:Oxidoreductases Acting on CH-NH Group Donors; D042965:Methylenetetrahydrofolate Reductase (NADPH2); D014805:Vitamin B 12